Table 2.

Relationship between CYP19 (TTTA)nrepeat polymorphism and prostate cancer risk

CYP19 variantOdds ratio*95% Confidence intervalP for trend
(TTTA)7 + TCT
    Two copies1.0 (reference)0.84
    One copy0.660.27-1.62
    None0.760.30-1.94
(TTTA)11
    Two copies1.0 (reference)0.64
    One copy1.330.80-2.22
    None1.030.58-1.83
  • * Adjusted for age.